Literature DB >> 16305294

Low-dose vitamin K to augment anticoagulation control.

Alicia M Reese1, Lisa E Farnett, Roger M Lyons, Bhavin Patel, Laura Morgan, Henry I Bussey.   

Abstract

STUDY
OBJECTIVES: To determine the effect of daily low-dose oral vitamin K supplementation on reducing variations in the international normalized ratios (INRs) in patients taking warfarin.
DESIGN: Retrospective analysis.
SETTING: Anticoagulation clinic in a large, private-practice hematology group. PATIENTS: Eight motivated patients (three men, five women), aged 45-79 years, receiving anticoagulant therapy with warfarin, whose INRs had been fluctuating for reasons not associated with identifiable changes in diet, warfarin dosage, activity level, illness, or changes in drug therapy. INTERVENTION: Daily supplementation with oral vitamin K, starting with 100 microg/day
MEASUREMENTS AND MAIN RESULTS: Anticoagulation providers monitored INR responses; all documented INR values were included in the analysis, even those intentionally allowed outside the therapeutic range when dosages were adjusted for procedures. After dietary vitamin K supplementation, INR fluctuations diminished in nearly all patients. Overall, a significant decrease was noted in the INR standard deviation (p<0.05), and more INRs were in the therapeutic range after the start of supplementation. Allowing for small fluctuations on either side of the target range, the number of INRs within 0.2 units of the target range increased from 32% to 57% (relative increase 76%). Time in range also increased by a similar degree.
CONCLUSION: Supplementation with daily low-dose oral vitamin K significantly increased the number of INRs in range as well as the time in range, and decreased INR fluctuation in this small series of selected patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16305294     DOI: 10.1592/phco.2005.25.12.1746

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  7 in total

Review 1.  Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Walter Ageno; Alexander S Gallus; Ann Wittkowsky; Mark Crowther; Elaine M Hylek; Gualtiero Palareti
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Case studies in anticoagulation management.

Authors:  Wendy A Leong
Journal:  J Thromb Thrombolysis       Date:  2007-10-01       Impact factor: 2.300

3.  Ezetimibe enhances and stabilizes anticoagulant effect of warfarin.

Authors:  Takehiro Hashikata; Minako Yamaoka-Tojo; Ryota Kakizaki; Teruyoshi Nemoto; Kazuhiro Fujiyoshi; Sayaka Namba; Lisa Kitasato; Takuya Hashimoto; Shunsuke Ishii; Ryo Kameda; Takao Shimohama; Taiki Tojo; Junya Ako
Journal:  Heart Vessels       Date:  2016-04-06       Impact factor: 2.037

Review 4.  Warfarin and vitamin K intake in the era of pharmacogenetics.

Authors:  Yael Lurie; Ronen Loebstein; Daniel Kurnik; Shlomo Almog; Hillel Halkin
Journal:  Br J Clin Pharmacol       Date:  2010-08       Impact factor: 4.335

5.  Does vitamin K supplementation improve vitamin K antagonist therapy? A case report and update of the literature.

Authors:  Sahar Vanessa Amiri; Johannes Jakobsen Sidelmann; Mustafa Vakur Bor
Journal:  J Cardiol Cases       Date:  2022-01-13

6.  Prospective study of supplemental vitamin K therapy in patients on oral anticoagulants with unstable international normalized ratios.

Authors:  Sarah K Ford; Caron P Misita; Betsy Bryant Shilliday; Robert M Malone; Charity G Moore; Stephan Moll
Journal:  J Thromb Thrombolysis       Date:  2007-02-24       Impact factor: 5.221

Review 7.  Measurement of non-VKA oral anticoagulants versus classic ones: the appropriate use of hemostasis assays.

Authors:  Jonathan Douxfils; Anne Tamigniau; Bernard Chatelain; Catherine Goffinet; Jean-Michel Dogné; François Mullier
Journal:  Thromb J       Date:  2014-11-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.